- Home
- SYRE vs SAFE Comparison
SYRE vs SAFE Comparison
Compare SYRE & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- SAFE
- Stock Information
- Founded
- SYRE 2013
- SAFE 2016
- Country
- SYRE United States
- SAFE United States
- Employees
- SYRE N/A
- SAFE N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- SAFE Real Estate Investment Trusts
- Sector
- SYRE Health Care
- SAFE Real Estate
- Exchange
- SYRE Nasdaq
- SAFE Nasdaq
- Market Cap
- SYRE 1.1B
- SAFE 1.2B
- IPO Year
- SYRE 2016
- SAFE 2017
- Fundamental
- Price
- SYRE $14.82
- SAFE $16.30
- Analyst Decision
- SYRE Strong Buy
- SAFE Buy
- Analyst Count
- SYRE 5
- SAFE 9
- Target Price
- SYRE $61.25
- SAFE $21.78
- AVG Volume (30 Days)
- SYRE 485.5K
- SAFE 343.4K
- Earning Date
- SYRE 11-06-2025
- SAFE 10-27-2025
- Dividend Yield
- SYRE N/A
- SAFE 4.35%
- EPS Growth
- SYRE N/A
- SAFE N/A
- EPS
- SYRE N/A
- SAFE 1.43
- Revenue
- SYRE N/A
- SAFE $393,596,000.00
- Revenue This Year
- SYRE N/A
- SAFE $0.59
- Revenue Next Year
- SYRE N/A
- SAFE $5.06
- P/E Ratio
- SYRE N/A
- SAFE $11.37
- Revenue Growth
- SYRE N/A
- SAFE 2.22
- 52 Week Low
- SYRE $10.91
- SAFE $13.43
- 52 Week High
- SYRE $40.26
- SAFE $28.80
- Technical
- Relative Strength Index (RSI)
- SYRE 34.55
- SAFE 55.78
- Support Level
- SYRE $15.80
- SAFE $15.92
- Resistance Level
- SYRE $17.58
- SAFE $16.90
- Average True Range (ATR)
- SYRE 0.74
- SAFE 0.48
- MACD
- SYRE -0.24
- SAFE -0.01
- Stochastic Oscillator
- SYRE 5.32
- SAFE 48.72
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.